High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

Publication date: Available online 18 March 2020Source: Reports of Practical Oncology & RadiotherapyAuthor(s): Sara Montemuiño, Núria Rodriguez de Dios, Margarita Martín, Begoña Taboada, Patricia Calvo-Crespo, María Pilar Samper-Ots, José Luis López-Guerra, M. López-Mata, Josep Jové-Teixidó, Verónica Díaz-Díaz, Lourdes de Ingunza-Barón, Mauricio Murcia-Mejía, Marisa Chust, Tamara García-Cañibano, María Luz Couselo, María Mar Puertas, Elia del Cerro, Javier. Moradiellos, Sergio Amor, A. Varela
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research